The Biggest Winners and Losers of JPM 2018
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the "winners and losers" from the conference. Source: BioSpace
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the "winners and losers" from the conference. Source: BioSpace
resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace
On Jan. 8, Alder BioPharma announced that its eptinezumab met its primary endpoint in its Phase III PROMISE 2 clinical trial for preventing migraine. Source: BioSpace
Strongbridge will fund 70% of the costs of a worldwide pediatric development program to be run by Aeterna Zentaris with customary oversight from a joint steering committee. Source: BioSpace
There are many unusual things about Shepherd Therapeutics, but one of them is its origin. Source: BioSpace
This not the first time Maraganore has tweeted his support for the benefits of immigration. Source: BioSpace
The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said. Source: BioSpace
The company, which now has 11 personnel, is a CRO focused on infectious disease research. Source: BioSpace
Vaccitech is an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products. Source: BioSpace
Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem. Source: BioSpace